 IRVINE, Calif., Aug. 09, 2021 GLOBE NEWSWIRE -- Oncocyte Corporation Nasdaq: OCX, a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced that management will participate at two upcoming investor conferences. 